Affordable Access

Access to the full text

Enhancing the anticoagulant profile of meizothrombin

Authors
  • Stojanovski, Bosko M.
  • Pelc, Leslie A.
  • Zuo, Xiaobing
  • Pozzi, Nicola
  • Cera, Enrico Di
Type
Published Article
Journal
Biomolecular Concepts
Publisher
De Gruyter
Publication Date
Dec 26, 2018
Volume
9
Issue
1
Pages
169–175
Identifiers
DOI: 10.1515/bmc-2018-0016
Source
De Gruyter
Keywords
License
Green

Abstract

Meizothrombin is an active intermediate generated during the proteolytic activation of prothrombin to thrombin in the penultimate step of the coagulation cascade. Structurally, meizothrombin differs from thrombin because it retains the auxiliary Gla domain and two kringles. Functionally, meizothrombin shares with thrombin the ability to cleave procoagulant (fibrinogen), prothrombotic (PAR1) and anticoagulant (protein C) substrates, although its specificity toward fibrinogen and PAR1 is less pronounced. In this study we report information on the structural architecture of meizothrombin resolved by SAXS and single molecule FRET as an elongated arrangement of its individual domains. In addition, we show the properties of a meizothrombin construct analogous to the anticoagulant thrombin mutant W215A/E217A currently in Phase I for the treatment of thrombotic complications and stroke. The findings reveal new structural and functional aspects of meizothrombin that advance our understanding of a key intermediate of the prothrombin activation pathway.

Report this publication

Statistics

Seen <100 times